BioSpace News Archive

Stalicla SA announces the successful completion of the first closing of its Series B financing round, securing $17.4 million.

ANI Pharmaceuticals, Inc. announced that it received U.S. Food and Drug Administration approval for the Abbreviated New Drug Application for Indomethacin Oral Suspension, USP.

Asensus Surgical, Inc. announced that Nagoya University Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in their Pediatric Surgery Department, at the end of December 2023.

Immuron Limited is pleased to announce record half yearly sales of its over-the-counter gastrointestinal and digestive health immune supplement Travelan®.

Cognigenics, Inc. is proud to announce the appointment of David Pyrce as its new Chief Executive Officer.

ASCEND Cardiovascular’s newest technology, Catalyst LIVE, currently implemented at two pioneering hospital sites, has pilots underway since 2022 at Stanford Medicine Children’s Health in California and Cook County Health in Illinois.

Eyenovia, Inc., a commercial-stage, ophthalmic company, announced that it has re-acquired the rights to MicroPine in the U.S. and Canada.

Theriva Biologics, Inc. (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that Company’s Management will participate in a fireside chat at the B. Riley Securities Oncology Conference to be held virtually on Thursday, January 18, 2024 at 9:30 a.m. ET.

Biora Therapeutics, Inc., the biotech company that is reimagining therapeutic delivery, provided guidance on anticipated milestones during 2024.

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, will exhibit its latest Cell and Gene Therapy innovations at Advanced Therapies Week, taking place at the Miami Beach Convention Center from January 16-19.